HomeCompareTKCBY vs JNJ

TKCBY vs JNJ: Dividend Comparison 2026

TKCBY yields 3.01% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $9.0K in total portfolio value· pulled ahead in Year 7
10 years
TKCBY
TKCBY
● Live price
3.01%
Share price
$23.50
Annual div
$0.71
5Y div CAGR
-19.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$37.90
Full TKCBY calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — TKCBY vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTKCBYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TKCBY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TKCBY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKCBY
Annual income on $10K today (after 15% tax)
$255.94/yr
After 10yr DRIP, annual income (after tax)
$32.21/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $4,005.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKCBY + JNJ for your $10,000?

TKCBY: 50%JNJ: 50%
100% JNJ50/50100% TKCBY
Portfolio after 10yr
$25.9K
Annual income
$2,393.89/yr
Blended yield
9.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TKCBY
No analyst data
Altman Z
1.6
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKCBY buys
0
JNJ buys
0
No recent congressional trades found for TKCBY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTKCBYJNJ
Forward yield3.01%2.14%
Annual dividend / share$0.71$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-19.4%28%
Portfolio after 10y$21.4K$30.5K
Annual income after 10y$37.90$4,749.88
Total dividends collected$1.2K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TKCBY vs JNJ ($10,000, DRIP)

YearTKCBY PortfolioTKCBY Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,943$242.69$10,594$274.49+$349.00TKCBY
2$11,909$200.04$11,294$360.69+$615.00TKCBY
3$12,906$163.99$12,133$476.91+$773.00TKCBY
4$13,944$133.88$13,156$635.42+$788.00TKCBY
5$15,029$108.95$14,432$854.61+$597.00TKCBY
6$16,169$88.46$16,056$1,162.76+$113.00TKCBY
7← crossover$17,373$71.69$18,175$1,604.53$802.00JNJ
8$18,647$58.02$21,009$2,252.68$2.4KJNJ
9$19,999$46.91$24,911$3,229.73$4.9KJNJ
10$21,437$37.90$30,458$4,749.88$9.0KJNJ

TKCBY vs JNJ: Complete Analysis 2026

TKCBYStock

Tokai Carbon Co., Ltd. manufactures and sells carbon-related products and services in Japan. It offers graphite electrodes for use in electric furnaces, such as direct current, alternating current, and refining furnaces; and carbon black, including SEAST, TOKABLACK, Aqua Black, and Thermal black varieties, which are used to reinforce the rubber in tires, as well as used as a black pigment in various black-colored products. It also provides fine carbon products comprising special graphite products that include isotropic graphite G/HK series, extruded graphite, SiC coated carbon, C/C composite, glassy carbon, solid SiC, carbon brush, and resin-impregnated graphite products, as well as furnace materials for silicon semiconductor, solar cell manufacturing, and other applications; and industrial furnaces and related products, which comprise silicon carbide heating elements, resistors, recryte SiC structural materials, and industrial furnaces for heat treatment of ceramics, electronic components, metals, glass, and others. In addition, it provides carbon and graphite products and solutions for various smelting applications; and friction materials, including sintered metal friction, paper friction, carbonaceous friction, sliding, resin, woven, and soft mold materials to regulate power transmission in industrial and construction machinery, as well as for use in brake and clutch parts of vehicles, such as motorbikes, trucks, buses, and trains. Further, the company offers anode materials for secondary lithium-ion batteries that are used in smartphones and electric cars. The company was formerly known as Tokai Electrode Mfg. Co. Ltd. and changed its name to Tokai Carbon Co., Ltd. in 1975. Tokai Carbon Co., Ltd. was founded in 1918 and is headquartered in Tokyo, Japan.

Full TKCBY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TKCBY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKCBY vs SCHDTKCBY vs JEPITKCBY vs OTKCBY vs KOTKCBY vs MAINTKCBY vs ABBVTKCBY vs MRKTKCBY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.